Business

You May Be Owed Money if You Bought Generic Prescription Drugs Between 2009 and 2019

By Mike Harper · August 3, 2026

If you filled a generic prescription between 2009 and 2019, a drug company may owe you money. The claim deadline is November 9.

Swiss generic drugmaker Sandoz agreed Monday to pay $450 million to 43 U.S. states and territories to resolve allegations that it conspired with other generic drug manufacturers to fix prices, rig bids, and divide up customers for hundreds of commonly prescribed medications. Sandoz denied wrongdoing.

The settlement is part of a broader legal effort by state attorneys general and federal authorities targeting an industry-wide scheme that allegedly inflated the cost of generic drugs for a decade. Three related settlements — totaling $533 million from Sandoz, Sun Pharmaceutical/Taro, and Heritage/Apotex combined — have already received final court approval. And a consumer claims portal is open now.

Any person in the United States who paid for one of the named generic drugs between May 2009 and December 2019 — whether through insurance copays, out-of-pocket costs, or reimbursement — may be eligible to file a claim. The deadline to submit a claim is November 9, 2026. Claims can be filed online at genericdrugsendpayersettlement.com or by mail. Proof of purchase — pharmacy receipts, insurance statements, or account records — is required.

The drugs involved span dozens of categories: antibiotics, heart medications, dermatology treatments, blood pressure drugs, and cholesterol medications. If you took a generic prescription during that period, there’s a reasonable chance at least one of your medications is on the list.

The litigation centers on what prosecutors described as coordinated pricing. Rather than competing on price — the entire purpose of the generic drug market — manufacturers allegedly agreed among themselves which companies would sell which drugs and at what price. State attorneys general uncovered evidence that competing executives secretly coordinated through meetings, phone calls, and texts, sometimes using coded language.

Monday’s $450 million Sandoz settlement with 43 states is separate from the consumer claims process but part of the same underlying case. Under the state settlement, Sandoz’s U.S. subsidiary will pay $400 million in installments over seven years beginning in 2027, plus approximately $50 million to states that settled earlier.

Separate state attorney general consumer refund programs are also in development. A registration site at AGGenericDrugs.com allows consumers to sign up for notifications when those state-level claim forms open — though no timeline has been announced.

The first trial against manufacturers who have not settled is expected in Hartford, Connecticut, in late 2026. The investigation is ongoing, and more settlements are likely.

For now, the consumer claim portal is live, the deadline is November 9, and checking whether your medications are on the list costs nothing.